| 注册
首页|期刊导航|中国食品药品监管|抗体类产品病毒安全控制探讨

抗体类产品病毒安全控制探讨

吕小红 冯巧巧 刘荣 明奕 胡敬峰

中国食品药品监管Issue(7):88-93,6.
中国食品药品监管Issue(7):88-93,6.DOI:10.3969/j.issn.1673-5390.2024.07.010

抗体类产品病毒安全控制探讨

Discussion on Viral Safety Control of Antibody Products

吕小红 1冯巧巧 1刘荣 1明奕 1胡敬峰1

作者信息

  • 1. 山东省食品药品审评查验中心
  • 折叠

摘要

Abstract

Virus safety control is crucial for the production quality of antibody products.This article summarizes the relevant issues regarding virus safety control of antibody products in pharmaceutical reviews and on-site inspections.Based on the latest revised ICH Q5A(R2)guidelines,the development of continuous manufacturing technology,and the technical requirements for platform validation,this article analyzes and discusses the virus safety control of antibody products,covering aspects such as facilities and equipment,cell banks,raw materials,auxiliary materials and consumables,upstream production processes,downstream purification processes,change control,etc.,in order to provide references and guidance for relevant production enterprises and regulatory agencies.

关键词

抗体类产品/病毒安全控制/细胞库/未处理收获液/病毒去除或灭活

Key words

antibody products/viral safety control/cell banks/unprocessed bulk/virus removal or inactivation

分类

医药卫生

引用本文复制引用

吕小红,冯巧巧,刘荣,明奕,胡敬峰..抗体类产品病毒安全控制探讨[J].中国食品药品监管,2024,(7):88-93,6.

中国食品药品监管

1673-5390

访问量0
|
下载量0
段落导航相关论文